Matthew A. Gubens
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 43
- Lung Cancer Research Studies 20
- Colorectal Cancer Treatments and Studies 13
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 60
- Lung Cancer Diagnosis and Treatment 28
- Gastric Cancer Management and Outcomes 6
- Immunology top 5%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 20
- Pathology and Forensic Medicine top 10%
-
- Esophageal Cancer Research and Treatment 6
- Co-authors
- Amita PatnaikLeena GandhiShirish M. GadgeelJames StevensonLecia V. SequistHossein BorghaeiCorey J. LangerJames Chih‐Hsin Yang
- Journals
- Journal of Clinical Oncology (27 papers)Journal of the American College of Cardiology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesSouth KoreaTaiwan
In The Last Decade
Matthew A. Gubens
97 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 2.3k
- Immunology 754
- Cancer Research 524
- Pathology and Forensic Medicine 208
Countries citing papers authored by Matthew A. Gubens
This map shows the geographic impact of Matthew A. Gubens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Gubens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Gubens more than expected).
Fields of papers citing papers by Matthew A. Gubens
This network shows the impact of papers produced by Matthew A. Gubens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Gubens. The network helps show where Matthew A. Gubens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew A. Gubens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 1 | |
| 5 | 2019 | 11 | |
| 6 | 2019 | 21 | |
| 7 | 2018 | 26 | |
| 8 | 2018 | 169 | |
| 9 | 2017 | 28 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 21 | |
| 12 | 2016 | 9 | |
| 13 | 2015 | 1 | |
| 14 | 2015 | 143 | |
| 15 | 2014 | 123 | |
| 16 | 2014 | 58 | |
| 17 | 2012 | 104 | |
| 18 | 2011 | 28 | |
| 19 | Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis | 2010 | 2 |
| 20 | 2004 | 139 |
About Matthew A. Gubens
Matthew A. Gubens is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 100 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (60 papers), Cancer Immunotherapy and Biomarkers (43 papers), Lung Cancer Diagnosis and Treatment (28 papers), Cancer Genomics and Diagnostics (20 papers), Lung Cancer Research Studies (20 papers), Colorectal Cancer Treatments and Studies (13 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (3.4k citations), Pulmonary and Respiratory Medicine (2.3k citations) and Immunology (754 citations). Matthew A. Gubens has collaborated with scholars based in United States, South Korea and Taiwan. Frequent co-authors include Amita Patnaik, Leena Gandhi, Shirish M. Gadgeel, James Stevenson, Lecia V. Sequist, Hossein Borghaei, Corey J. Langer, James Chih‐Hsin Yang, Shadia I. Jalal and Steven Powell. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.